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Our previous studies have shown good biocompatibility of fluorapatite (FA) crystal surfaces in providing a
favorable environment for functional cell–matrix interactions of human dental pulp stem cells (DPSCs) and also
in supporting their long-term growth. The aim of the current study was to further investigate whether this
enamel-like surface can support the differentiation and mineralization of DPSCs, and, therefore, act as a po-
tential model for studying the enamel/dentin interface and, perhaps, dentine/pulp regeneration in tooth tissue
engineering. The human pathway-focused osteogenesis polymerase chain reaction (PCR) array demonstrated
that the expression of osteogenesis-related genes of human DPSCs was increased on FA surfaces compared with
that on etched stainless steel (SSE). Consistent with the PCR array, FA promoted mineralization compared with
the SSE surface with or without the addition of a mineralization promoting supplement (MS). This was con-
firmed by alkaline phosphatase (ALP) staining, Alizarin red staining, and tetracycline staining for mineral
formation. In conclusion, FA crystal surfaces, especially ordered (OR) FA surfaces, which mimicked the physical
architecture of enamel, provided a favorable extracellular matrix microenvironment for the cells. This resulted in
the differentiation of human DPSCs and mineralized tissue formation, and, thus, demonstrated that it may be a
promising biomimetic model for dentin-pulp tissue engineering.
Introduction
Tooth loss caused by caries, periodontal diseases,trauma, and other diseases is common and seriously af-
fects the life quality of humans. Lost teeth are traditionally
replaced by artificial dentures or implants. However, artificial
dentures and implants are not physiologically or biologically
functional restorations of lost teeth. Recent advances in tissue
engineering and stem cell biology provide an attractive pros-
pect for dental pulp regeneration and repair of injured hard
tissues such as dentin and bone.1 For tooth or bone tissue-
engineering purposes, biocompatible and bioactive scaffolds,
responding mesenchymal cells, and inductive growth factors
are the three key ingredients. Among all the tissue-engineering
techniques, a biocompatible scaffold with appropriate chemi-
cal, physical, and mechanical properties is essential to the re-
pair and functional regeneration of impaired tissues. Ideally, it
is desirable that a scaffold should not only support the long-
term growth of specific cells but also direct the differentiation
of these cells toward the creation of functional tissues.
During tooth development, the formation of dentin is
achieved through epithelial signal-induced differentiation of
dental papilla mesenchymal cells into odontoblasts. After the
eruption of a tooth, the regeneration of dentin depends on
dental mesenchymal stem cells differentiating into odonto-
blasts. To date, a readily accessible source of such stem cells
is the dental pulp: the human dental pulp stem cells (DPSCs).
These cells provide, in a tissue-engineering sense, a promis-
ing approach to achieve dentin and pulp regeneration and
repair. Further through interactions with the enamel-like,
ordered (OR) fluorapitite (FA) crystal surfaces, eventually
help to create an enamel/dentin/pulp complex because
these cells are easily collected, have a rapid proliferation rate,
and multiple differentiation potentials.2,3
Earlier, we had demonstrated a method to generate
aligned FA crystal surfaces. The crystals were well aligned,
and the densely packed growth mode resulted in a highly
orientated enamel-like FA film.4 We have also reported the
initial cellular response of different cells to the OR and dis-
ordered (DS) FA crystal surfaces and explored the mecha-
nisms underlying this cellular response.5 Both the OR and DS
FA surfaces were shown to have good biocompatibility and
supported the long-term growth of DPSCs. We have also
reported an enhanced cellular response of DPSCs to the OR
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FA crystal surface, which involved a set of delicately regu-
lated matrix and adhesion molecules. This could be further
manipulated by treating the cells with a dentin inducing
supplement (dentin extract), to produce a dentin/enamel
superstructure.5,6 However, we had also shown that MG-63
cells grown on the FA surface were able to differentiate and
mineralize without treatment with an osteogenic induction
(OI) supplement.7 This suggested that the FA crystal films,
probably through their intrinsic properties and their surface
characteristics, may promote the differentiation and miner-
alization of dental mesenchymal stem cells without treat-
ment by dentinal soluble molecules or by a mineralization
inducing supplement.
Thus, in the present study, we aimed at investigating
whether FA crystal surfaces induce and promote the differ-
entiation and mineralization of human DPSCs and, as a result,
provide a scaffold for the dentin and pulp regeneration and,
potentially, a simple biomimetic model for creating an
enamel/dentin/pulp complex. The human pathway-focused
osteogenesis polymerase chain reaction (PCR) array was
performed to detect the expression of pathway-focused os-
teogenesis-related molecules. To prove our hypothesis and to
detect whether FA induced and promoted differentiation and
mineralization, staining for alkaline phosphatase (ALP) and
hard tissue formation was carried out on DPSCs cultured on
FA as well as etched stainless steel (SSE) surfaces with or
without a mineralization promoting supplement (MS).
Materials and Methods
Synthesis of the FA apatite surfaces
The synthesis and coating of the FA crystal on the SSE has
been carried out as previously described.4,7 Briefly, for a
typical synthesis of FA crystals, 9.36 g ethylenedeiaminete-
traacetic acid calcium disodium salt (EDTA-Ca-Na2) and
2.07 g NaH2PO4$H2O were mixed with distilled water to a full
volume of 90 mL. The suspension was continuously stirred
until the powder was completely dissolved. The pH was ad-
justed to 6.0 using NaOH. At the same time, 0.21 g NaF was
dissolved in 10 mL distilled water (pH 7.0) and continuously
stirred. The two solutions were mixed, and the FA crystal
growth on the substrates (15 mm 316 stainless steel discs) was
achieved by adding the plates to 200 mL of newly prepared
EDTA-Ca-Na2/NaH2PO4/NaF mixture and then autoclav-
ing at 121C at pressure of 2.4 · 105 Pa for 10 h. OR and DS
films were synthesized separately on the under surfaces and
upper surfaces of the stainless steel discs, respectively.
Cell culture and seeding
DPSCs (kindly donated by Dr. S. Shi, USC) were sub-
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 100 units/mL of
penicillin, and 100mg/mL of streptomycin, maintained at
37C in a humidified atmosphere containing 5% CO2. Before
cell seeding, the OR, DS FA, and SSE surfaces were incu-
bated with a culture medium for 2 h. DPSCs at passage 5
were then seeded onto the different surfaces at a density of
5 · 104 cells/mL in 12-well plates under the culture condi-
tions just described. After confluence, DPSCs were further
cultured with or without treatment of MS. The medium and
the supplements were replaced every 2 days.
ALP staining
After 1 week of culturing with or without MS of ascorbic
acid (50 mg/mL) and b-glycerophosphate (10 mM), DPSCs
grown on OR, DS, and SSE surfaces were washed with
phosphate-buffered saline (PBS) and fixed in 4% parafor-
maldehyde for 30 min, washed 3 · in dH2O, and then incu-
bated with 1 mg/mL Fast red TR (Sigma-Aldrich) and
0.5 mg/mL napthol AS-MX phosphate (Sigma-Aldrich) 0.1 M
Tris buffer (pH 9.2) containing 1% N,N dimethylformamide
(Sigma-Aldrich) for an ALP-substrate color reaction. After
incubation at 37C for 1 h, the cultures were washed twice in
PBS, counterstained in 4¢,6-diamidino-2-phenylindole (DAPI)
(300 mM, Invitrogen) for 10 min, and then further washed
twice in PBS before fluorescence imaging. Discs without cells
served as controls.
Scanning electron microscope observation
After 4 weeks of culture with or without mineralization
induction, the DPSCs grown on the different surfaces were
rinsed and fixed in 2.5% glutaraldehyde for 1 h, dehydrated
through a series of grade ethanol from 25% to 100%, and
then placed in a vacuumed desiccator to dry overnight.
Scanning electron microscope (SEM) analysis was conducted
on a Phillips XL30FEG SEM (FEI Company) operated at
10 kV. The SEM specimen was coated with an Au/Pd film to
prevent specimen charging.
Alizarin red staining and osteogenesis
quantitative assay
After 4 weeks, the cells grown on three different surfaces,
with or without the addition of MS, were collected for
Alizarin red staining according to the manufacturer’s in-
structions (Osteogenesis Assay Kit, Millipore). Briefly, the cells
were rinsed, fixed with 70% ethanol, incubated with Alizarin
red staining solution for 20 min, and washed with dH2O
4 · 5 min. After staining, the quantitative analysis was carried
out through the extraction of Alizarin red from stained sam-
ples using acetic acid according to the manufacturer’s proto-
cols. Three to five samples from each group were used for the
Alizarin red quantification. The Alizarin red concentration
was determined by the optical density value at absorbance of
405 nm. Discs without cells were also stained as controls.
RNA isolation and reverse transcription
Total cellular RNA was isolated from DPSCs grown for 4
weeks with or without MS treatment on the three different
surfaces using the RNeasy Mini kit according to the manu-
facturer’s instructions. The RNA was treated with the RNase-
free DNase Set during RNA isolation. The cDNA samples
were prepared from the isolated RNA using the reverse tran-
scription (RT) first-strand kit, according to the manufacturer’s
protocols. An average of eight replicates of each FA crystal
substrate on which the cells were grown was used for the total
cellular RNA isolation and cDNA sample preparation.
RT2 profiler PCR array analysis
The gene profile of each specimen was analyzed using the
human pathway-focused osteogenesis PCR array. Briefly, the
prepared cDNA samples were added to the RT2 qPCR
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master mix containing SYBR Green and reference dye.
The mixture just described was then aliquoted across the
PCR array templates that contain 84 human osteogenesis
pathway-specific genes plus controls. The real-time PCR
analysis was carried out using an ABI 7700 sequence detector
(Applied Biosystems). Relative gene expression values were
analyzed using the Superarray web-based software package
that performed all DDCt-based fold-change calculations,
which sets a change of at least twofold as the ‘‘cutoff’’ value
for the transcripts being differentially expressed in the ex-
perimental groups. Duplicate 96-well plates were used in this
PCR array analyses.
In vitro tetracycline staining
The growth of DPSCs on FA crystal surfaces under the
conditions just described was extended for an additional 2
weeks. After 6 weeks of induction, tetracycline, a bone fluo-
rochrome was administered to label mineralized tissue for-
mation. Briefly, the labeling medium (DMEM with 20mg/mL
FIG. 1. ALP fluorescence
staining of DPSCs grown on
OR, DS FA surfaces, and SSE
surfaces with or without
treatment of MS for 1 week.
(A) Without MS treatment.
(B) With MS treatment. (a)
DAPI nuclei staining; (b) ALP
staining; (c) merged picture of
(a) and (b). Scale bar repre-
sents 200mm. ALP, alkaline
phosphatase; DPSCs, human
dental pulp stem cells; OR,
ordered; DS, disordered; FA,
fluorapatite; SSE, etched
stainless steel; MS, minerali-
zation promoting supple-
ment. Color images available
online at www.liebertpub
.com/tec
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tetracycline) was freshly prepared, and then used for the last
feeding of cells grown on the experimental surfaces. After
staining, the discs with seeded cells were washed with
DMEM, fixed in 10% neutral buffered formalin, and embed-
ded in methyl methacrylate by routine histological methods.
Serial sections of 150mm thickness were cut from specimens
with a diamond saw, and then ground and polished to ap-
proximately 10mm using a microgrinding machine system
(D-2000; Exakt-Apparatebau). The sections were then ob-
served and imaged under fluorescence microcopy and further
stained using 1% toluidine blue for histological observation.
After that, the fluorescence pictures are merged with their
corresponding toluidine blue staining pictures.
Statistical analysis
The osteogenesis quantitative assay results were statisti-
cally analyzed using GraphPad Prism 5 for one-way analysis
of variance and Tukey’s post hoc test of an average of three to
five replicates, and significance was considered at p < 0.05.
Data are expressed as means – standard deviation.
Results
ALP staining
ALP-positive cells were stained red, and cell nuclei were
stained blue. After 1 week, without MS treatment, a few
ALP-positive cells could be seen in DPSCs grown on OR and
DS surfaces. No identifiable ALP-positive staining was found
in the DPSCs grown on SSE surfaces (Fig. 1A). With MS
treatment, there was obvious ALP staining in all groups.
However, the DPSCs grown on OR and DS surfaces dis-
played much stronger ALP staining compared with those on
the SSE surfaces. Stronger ALP staining could also be ob-
served in the DPSCs grown on OR surfaces than in those on
DS surfaces (Fig. 1B).
SEM observation
To observe the mineral deposition and mineralized matrix
formation on the experimental surfaces, the cellular layers
were mechanically removed before specimen processing.
After 4 weeks, mineral nodules were seen on both DS and
OR FA surfaces with and even without MS. However, either
with or without MS, more densely deposited nodules com-
bined with a cellular matrix were observed on the OR FA
surface compared with the DS one (Fig. 2). No SEM pictures
of the SSE surface were able to be taken, as the whole surface
layers were easily removed after the cells had been detached.
Alizarin red staining
After 4 weeks, without MS treatment, positive Alizarin red
staining was seen in DPSCs grown on OR and DS surfaces,
whereas no positive staining was observed in cells grown on
SSE surfaces. With MS treatment, DPSCs grown on OR, DS,
and SSE surfaces all displayed obvious Alizarin red staining.
The staining intensity of cells grown on OR and DS surfaces
was much stronger than that on SSE surfaces (Fig. 3). A
subsequent quantitative osteogenesis assay was consistent
with the results just cited (Fig. 4).
In vitro tetracycline staining
After being cultured with or without MS treatment on SSE
and the FA-coated discs for 6 weeks, the cells grown on both
the FA surfaces showed identifiable fluorescence staining for
mineralized tissue formation. The OR FA stimulated evident
mineralized tissue integration within the crystal layer, and this
fluorescence staining, after being merged, overlapped with a
similar obvious toluidine blue staining (Fig. 5). However, there
was no identifiable staining for hard tissue formation in SSE
groups and slightly positive fluorescence staining in DS sur-
faces with or without MS treatment (data not shown).
FIG. 2. Scanning electron
micrograph of mineral nodule
formation of DPSCs grown on
OR and DS surfaces after treat-
ment with or without MS for
4 weeks.
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Human pathway-focused osteogenesis
PCR array analysis
Osteogenesis PCR array analysis was carried out to com-
pare the gene profiles of DPSCs grown on SSE surfaces with
that of the cells grown on OR and DS surfaces, with or
without MS treatment at the time point of 4 weeks. We also
compared the gene profile differences between the cells
grown on the OR and DS FA surfaces at this time point.
Osteogenesis profiles of DPSCs grown on an OR FA
crystal surface were carried out. Without MS, a total of 9
genes out of 84 genes were differentially regulated when
the cells were grown on the OR compared with the SSE
surface, with seven genes up-regulated and two genes down-
regulated (Table 1A).
With MS, a total of 16 genes were differentially regulated
when DPSCs were grown on an OR FA surface compared with
those on the SSE surface. Fifteen genes were up-regulated,
among which the expression of runt-related transcription factor
2 (RUNX2) was regulated with an over 1000-times fold change.
The gene of fibroblast growth factor 2 (FGF2) was down-regu-
lated in DPSCs grown on an OR FA surface (Table 1B).
Osteogenesis profiles of DPSCs grown on a DS FA crystal
surface were carried out. Without MS, there were 16 genes
differentially regulated when DPSCs were grown on the DS
FA surface compared with those seeded on the SSE surface.
A total of 10 genes were stimulated, including collagen, type
X, alpha 1 (COL10A1) and phosphate-regulating endopepti-
dase homolog, Xlinked (Phex), and six genes inhibited by the
DS FA surface (Table 2A).
With MS, a total of 17 genes were differentially regulated
when DPSCs were grown on the DS FA surface compared
with those on the SSE surface. Fourteen genes were up-
regulated, with an 1139-times RUNX2 up-regulation. The
other three genes, bone morphogenetic protein 6 (BMP6),
FIG. 3. Alizarin red staining
of DPSCs grown on OR, DS,
and SSE surfaces with or
without MS treatment for 4
weeks. After 4 weeks, the cells
grown on three different
surfaces, with or without the
addition of MS, were collected
for Alizarin red staining
according to the manufactur-
er’s instructions (Osteogenesis
Assay Kit, Millipore). Control,
substrates only without cells.
Color images available online
at www.liebertpub.com/tec
FIG. 4. Osteogenesis quantitative assay of DPSCs grown on
OR, DS, and SSE surfaces with or without MS treatment for 4
weeks. After staining, the quantitative analysis was carried
out through the extraction of Alizarin red from stained
samples using acetic acid according to the manufacturer’s
protocols (Osteogenesis Assay Kit, Millipore). Three to five
samples from each surface were used for one-way analysis of
variance and Tukey’s post hoc test, and significance was
considered at p < 0.05. (*p < 0.05).
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FIG. 5. Tetracycline fluo-
rescence staining of DPSCs
on OR FA surface with or
without MS treatment for 6
weeks. (A) After DPSCs
growing on OR FA surfaces
with and without MS for 6
weeks, tetracycline, a bone
fluorochrome was adminis-
tered to label the newly
formed bone-like mineralized
tissue. (B) Toluidine blue was
used to stain organic tissue
components. (C) Merged pic-
tures of staining A and B.
Scale bar length: 200 mm.
Color images available online
at www.liebertpub.com/tec
Table 1A. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Ordered Fluorapatite Surface Relative to the Etched Stainless
Steel Surfaces at 4 Weeks (Without Mineralization Promoting Supplement)
Symbol Unigene Ref. seq Description Fold change
BGN Hs.821 NM_001711 Biglycan 2.27
COL10A1 Hs.520339 NM_000493 Collagen, type X, alpha 1 6.88
COL15A1 Hs.409034 NM_001855 Collagen, type XV, alpha 1 2.33
COL3A1 Hs.443625 NM_000090 Collagen, type III, alpha 1 2.04
COMP Hs.1584 NM_000095 Cartilage oligomeric matrix protein 3.87
ENAM Hs.667018 NM_031889 Enamelin 1.92
PHEX Hs.495834 NM_000444 Phosphate regulating endopeptidase homolog, X-linked 2.0
CD36 Hs.120949 NM_000072 CD36 molecule (thrombospondin receptor) - 2.94
ITGAM Hs.172631 NM_000632 Integrin, alpha M (complement component 3 receptor 3 subunit) - 3.41
Table 1B. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Ordered Fluorapatite Surface Relative to the Etched Stainless
Steel Surfaces at 4 Weeks (With Mineralization Promoting Supplement)
Symbol Unigene Ref. seq. Description Fold change
AHSG Hs.324746 NM_001622 Alpha-2-HS-glycoprotein 2.62
BMP4 Hs.68879 NM_130851 Bone morphogenetic protein 4 2.0
COL10A1 Hs.520339 NM_000493 Collagen, type X, alpha 1 13.57
COL11A1 Hs.523446 NM_080629 Collagen, type XI, alpha 1 3.12
DMP1 Hs.652366 NM_004407 Dentin matrix acidic phosphoprotein 1 6.83
ENAM Hs.667018 NM_031889 Enamelin 5.11
FGF1 Hs.483635 NM_000800 Fibroblast growth factor 1 (acidic) 2.40
FGFR2 Hs.533683 NM_000141 Fibroblast growth factor receptor 2 2.21
ITGA1 Hs.644352 NM_181501 Integrin, alpha 1 2.12
MMP10 Hs.2258 NM_002425 Matrix metallopeptidase 10 (stromelysin 2) 3.32
MMP9 Hs.297413 NM_004994 Matrix metallopeptidase 9
(gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)
2.25
RUNX2 Hs.535845 NM_004348 Runt-related transcription factor 2 1153.66
SMAD1 Hs.604588 NM_005900 SMAD family member 1 2.48
STATH Hs.654495 NM_003154 Statherin 4.67
TGFB3 Hs.592317 NM_003239 Transforming growth factor, beta 3 2.64
FGF2 Hs.284244 NM_002006 Fibroblast growth factor 2 (basic) - 2.62
After the real-time PCR amplification, relative gene expression values were analyzed using the Superarray web-based software package
performing all DDCt
-based fold-change calculations.
PCR, polymerase chain reaction.
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FGF2, and CD36, were down-regulated in DPSCs grown on
the DS FA surface with MS treatment (Table 2B).
Osteogenesis profiles of DPSCs grown on OR and DS FA
crystal surfaces were carried out. Without MS, a total of four
genes were differentially regulated when DPSCs were grown
on an OR FA surface compared with those on the DS FA
surface. BMP4, dentin matrix acidic phosphoprotein 1
(DMP1), and dentin sialophosphoprotein (DSPP) were up-
regulated, while COL10A1 was down-regulated (Table 3A).
With MS, a total of seven genes were differentially regu-
lated. The OR FA stimulated six genes, including DMP1,
matrix metallopeptidase 10 (MMP10), and transforming
growth factor, beta 3 (TGFb3). The Fms-related tyrosine ki-
nase 1 (FLT1) was down-regulated (Table 3B).
Discussion
In our laboratory, we have synthesized a highly orientated
FA film with a prism-like structure that is similar to human
enamel. As is well known, natural bone accumulates fluoride
ions from the blood, forming a fluoride containing HA.
Fluoride ions within the lattice replace hydroxide ions, cre-
ating a tighter lattice structure. It is, thus, possible that this FA
crystal scaffold could also be applied for various orthopaedic
applications. In our previous article, we have discussed the
use of the OR FA films as surface preparations that encourage
bony integration in dental and orthopedic applications.5,7 In
this study, we used this enamel-like surface structure as a
biomimetic interface between the FA crystals and the DPSCs
Table 2A. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Disordered Fluorapatite Surface Relative to the Etched Stainless
Steel Surfaces at 4 Weeks (Without Mineralization Promoting Supplement)
Symbol Unigene Ref. seq. Description Fold change
BGN Hs.821 NM_001711 Biglycan 2.30
BMP5 Hs.296648 NM_021073 Bone morphogenetic protein 5 2.13
COL10A1 Hs.520339 NM_000493 Collagen, type X, alpha 1 15.05
COL15A1 Hs.409034 NM_001855 Collagen, type XV, alpha 1 2.50
COL3A1 Hs.443625 NM_000090 Collagen, type III, alpha 1 2.30
COMP Hs.1584 NM_000095 Cartilage oligomeric matrix protein 4.83
FGF1 Hs.483635 NM_000800 Fibroblast growth factor 1 (acidic) 2.0
PHEX Hs.495834 NM_000444 Phosphate regulating endopeptidase homolog, X-linked 2.0
TGFB1 Hs.645227 NM_000660 Transforming growth factor, beta 1 2.04
VDR Hs.524368 NM_000376 Vitamin D (1,25-dihydroxyvitamin D3) receptor 2.04
ALPL Hs.75431 NM_000478 Alkaline phosphatase, liver/bone/kidney - 2.01
BMP4 Hs.68879 NM_130851 Bone morphogenetic protein 4 - 2.17
DMP1 Hs.652366 NM_004407 Dentin matrix acidic phosphoprotein 1 - 3.89
DSPP Hs.678914 NM_014208 Dentin sialophosphoprotein - 2.51
IGF2 Hs.523414 NM_000612 Insulin-like growth factor 2 (somatomedin A) - 2.41
ITGAM Hs.172631 NM_000632 Integrin, alpha M (complement component 3 receptor 3 subunit) - 3.75
Table 2B. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Disordered Fluorapatite Surface Relative to the SSE Surfaces
at 4 Weeks (With Mineralization Promoting Supplement)
Symbol Unigene Ref. seq. Description Fold change
AHSG Hs.324746 NM_001622 Alpha-2-HS-glycoprotein 2.05
COL10A1 Hs.520339 NM_000493 Collagen, type X, alpha 1 14.36
COL11A1 Hs.523446 NM_080629 Collagen, type XI, alpha 1 2.0
DMP1 Hs.652366 NM_004407 Dentin matrix acidic phosphoprotein 1 2.23
ENAM Hs.667018 NM_031889 Enamelin 3.93
FGF1 Hs.483635 NM_000800 Fibroblast growth factor 1 (acidic) 2.74
IGF1 Hs.160562 NM_000618 Insulin-like growth factor 1 (somatomedin C) 2.40
IGF1R Hs.643120 NM_000875 Insulin-like growth factor 1 receptor 2.06
ITGA1 Hs.644352 NM_181501 Integrin, alpha 1 2.09
MMP8 Hs.161839 NM_002424 Matrix metallopeptidase 8 (neutrophil collagenase) 2.70
MMP9 Hs.297413 NM_004994 Matrix metallopeptidase 9
(gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)
2.0
RUNX2 Hs.535845 NM_004348 Runt-related transcription factor 2 1139.35
SMAD1 Hs.604588 NM_005900 SMAD family member 1 2.50
STATH Hs.654495 NM_003154 Statherin 2.18
BMP6 Hs.285671 NM_001718 Bone morphogenetic protein 6 - 2.21
CD36 Hs.120949 NM_000072 CD36 molecule (thrombospondin receptor) - 4.31
FGF2 Hs.284244 NM_002006 Fibroblast growth factor 2 (basic) - 2.21
After the real-time PCR amplification, relative gene expression values were analyzed using the Superarray web-based software package
performing all DDCt
-based fold-change calculations.
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to investigate its influence on their differentiation and
mineralization. This was an attempt to establish the FA
surfaces as a scaffold for dentin and pulp regeneration and,
potentially, as a simple biomimetic model for the creation of
an enamel/dentin/pulp complex of the tooth.
As in tissue engineering, the well-designed, biomimetic
biomaterials or scaffolds are crucial in determining and/or
directing the pathway of recruited stem cell differentiation
and related new tissue regeneration. Earlier, it was demon-
strated that molecules solubilized from the dentin are key in
promoting the DPSCs to differentiate and produce a miner-
alized dentin-like tissue.8 In the present study, ALP staining
was carried out to show the differentiation of DPSCs, as ALP
expression is widely accepted as an earlier marker for the
differentiation of cells forming hard tissues. However, Ali-
zarin red staining, as well as its related osteogenesis quanti-
tative assay, and tetracycline staining were used to study the
late-stage mineralized tissue formation. These results, along
with the SEM observation showing mineral nodule forma-
tion, suggested that, even without treatment by dentinal
soluble molecules or by an MS, DPSCs grown on enamel-like
FA surfaces were capable of differentiating into mineralized
tissue forming cells and undergoing a subsequent minerali-
zation process. This is consistent with our previous work
showing that MG-63 cells grown on the FA surface were able
to differentiate and mineralize even without OI.7
The osteogenesis gene profile analysis was performed to
help us explain the mechanisms underlying this DPSC dif-
ferentiation and mineralization process. As shown in the
results, the FA crystal surfaces stimulated the expression of
several collagen genes, including collagen type X, XI, and XV
with or without MS treatment. A previous study has shown
that mutations of collagen type XI resulted in severe abnor-
malities of bone, which would usually lead to the death of
the animals at birth. It was suggested that collagen type XI
may have an important function in solid connective tissue
development.9 The up-regulation of collagen type XI and the
other collagen genes by the OR FA surfaces are likely to
provide a favorable microenvironment for the differentiation
of DPSCs with or even without MS treatment.
The Phex, a transmembrane metalloendoprotease, is
found to be predominantly localized in teeth and bone. Since
it is critical to the process of bone mineralization, it is com-
monly thought to be one of the required genes for normal
bone formation and the process of biomineralization.10,11
Without MS treatment, a similar up-regulation of Phex ex-
pression was detected on both OR and DS FA surfaces
compared with the SSE surface. This would suggest that both
OR and DS FA surfaces may stimulate biomineralization
through enhanced Phex expression.
With MS, it is most noticeable that Runx2 is significantly
up-regulated in cells grown on both OR and DS FA surfaces.
Runx2, a downstream target of BMP signaling, is a master
transcription factor of the bone that is necessary for the dif-
ferentiation of pluripotent mesenchymal cells to osteoblasts.
Runx2 is required in maintaining fully functional cells and is
essential for the initial commitment of mesenchymal cells to
the osteoblastic lineage. Runx2 also controls the proliferation,
differentiation, and maintenance of these cells.12–14 Runx2 is
affected by a diversity of signaling pathways. The binding of
extracellular matrix (ECM) proteins to cell-surface integrins,
FGF2, and BMPs influences Runx2-dependent transcrip-
tion.15,16 Runx2 has also been suggested to be essential for
tooth development.17,18 It is increasingly expressed in early
odontoblasts, but is either low or undetectable in differenti-
ated odontoblasts.19,20 Interestingly, Runx2 increased DSPP
expression in immature odontoblasts, but down-regulated its
expression in more mature cells, showing that the effect of
Table 3A. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Ordered Fluorapatite Surface Relative to the Disordered
Surfaces at 4 Weeks (Without Mineralization Promoting Supplement)
Symbol Unigene Ref. seq. Description Fold change
BMP4 Hs.68879 NM_130851 Bone morphogenetic protein 4 2.45
DMP1 Hs.652366 NM_004407 Dentin matrix acidic phosphoprotein 1 3.18
DSPP Hs.678914 NM_014208 Dentin sialophosphoprotein 2.0
COL10A1 Hs.520339 NM_000493 Collagen, type X, alpha 1 2.19
Table 3B. Fold Change of the Human Pathway-Focused Osteogenesis Molecules Expressed by the Dental
Pulp Stem Cells Grown on the Ordered Fluorapatite Surface Relative to the Disordered
Surfaces at 4 Weeks (With Mineralization Promoting Supplement)
Symbol Unigene Refseq Description Fold change
BMP6 Hs.285671 NM_001718 Bone morphogenetic protein 6 2.0
CD36 Hs.120949 NM_000072 CD36 molecule (thrombospondin receptor) 8.39
DMP1 Hs.652366 NM_004407 Dentin matrix acidic phosphoprotein 1 3.07
MMP10 Hs.2258 NM_002425 Matrix metallopeptidase 10 (stromelysin 2) 2.43
STATH Hs.654495 NM_003154 Statherin 2.14
TGFB3 Hs.592317 NM_003239 Transforming growth factor, beta 3 2.0
FLT1 Hs.654360 NM_002019 Fms-related tyrosine kinase 1 (vascular endothelial
growth factor/vascular permeability factor receptor)
- 2.22
After the real-time PCR amplification, relative gene expression values were analyzed using the Superarray web-based software package
performing all DDCt based fold-change calculations.
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Runx2 is dependent on the state of differentiation of the
target cells.21
Among numerous ECM molecules, DMP1 is a bone-, as
well as a tooth, specific protein. It was initially identified
from mineralized dentin and is believed to be involved in the
regulation of mineralization and apatite deposition.22 DMP1
is crucial in the maturation of odontoblasts and osteoblasts
and in the biomineralization process.23 In the dentin–pulp
complex, DMP1 can act as a morphogen in undifferentiated
mesenchymal cells, and induce the odontoblast differentia-
tion of DPSCs, as well as dentin-like tissue regeneration.24 In
addition, DMP1 has been shown to nucleate apatite crystals
and to induce dentin formation.25 Both DMP1 and Phex are
significantly involved in maintaining appropriate serum
phosphate levels required for the normal mineralization of
teeth and bone.26 In our study, without MS treatment, the
DMP1 expression was 3.8-fold inhibited in DPSCs on a DS
FA surface, while with MS treatment, it was greatly up-
regulated on both OR and DS FA surfaces compared with
the SSE surface. With or without MS treatment, the up-
regulation of DMP1 was shown in cells grown on an OR FA
surface compared with those on a DS FA surface. Since
DMP1 is considered one of the key phenotypic mineraliza-
tion markers, this result was in accordance with the miner-
alization data, which detected much more mineral formation
on OR FA surfaces than on DS FA surfaces with or without
MS. In addition, with MS, the enhanced DMP1 expression is
consistent with the stronger tetracycline staining of the new
mineral formation on FA surfaces.
In our study, the BMP4 and SMAD1 expression of DPSCs
grown on FA surfaces was enhanced with MS treatment, but
the expression of BMP4 was inhibited in the cells on DS FA
surfaces. Promisingly, the BMP4 and BMP6 expression was
up-regulated in cells grown on an OR FA surface compared
with those on DS FA. Earlier studies demonstrated that BMPs
trigger signaling events which induce dentin formation in
animal models.27,28 Among the 15 known human BMPs, BMP4
has been shown to induce undifferentiated mesenchymal stem
cells to differentiate into chondroblasts or osteoblasts.29
In a previous study, the activation of insulin-like growth
factor (IGF) and epidermal growth factor (EGF) pathways has
been proved to be closely related to the osteogenesis induction
of BMP6,30 whereas, in our study, the up-regulation of IGF1
was coordinated with the down-regulation of BMP6 in MS-
treated groups, suggesting that other BMPs members and
growth factors may be actively involved in the activation of
IGF pathways. Compared with the SSE group, the expression
of FGF1 was stimulated on both the OR and DS FA surfaces,
whereas the FGF2 were inhibited on FA surfaces with MS
treatment, indicating the involvement of FGF signaling path-
way during this process. Significantly, FGF1 has been shown
to have duel effects on favoring both angiogenesis and os-
teogenesis, which are crucial in the physiology of the bone
development and repair process.31 Moreover, our study
showed the up-regulation of growth factors such as TGFb1
and TGFb3 by the FA surfaces with or without MS. This is
consistent with a previous study that the TGFb and FGF
family genes appear to be vital in mediating the odontoblast
differentiation process.32
It is also noteworthy that DPSCs behavior differed when
seeded on the OR and DS FA surfaces, suggesting that the
surface topography of the FA substrate could affect this apa-
tite-directed cell initial adhesion, growth and differentiation,
and related mineralization process.5,7 It is now well accepted
that besides the intrinsic characteristics of a substrate, for ex-
ample, chemical compositions, charge, and hydrophobicities,
the topographical features such as mechanics and the geo-
metric microenvironment also show the potential to direct cell
responses, including different cell fate selections. Discher re-
viewed the response of various cells on different stiffness of a
substrate, implying this physical property modulates cell or
tissue development, differentiation, and the regeneration
process. Moreover, Vogel and Sheetz’ review reported the
capabilities of cells in sensing the force or geometry of a ma-
terial, such as substrate rigidity and microstructure, to transfer
these physical and geometrical signals into cellular biochemi-
cal signals that regulate various cellular activities. Poellmann
et al. also showed cell morphological changes to different
geometric microenvironments using quantitative measure-
ments.33–35 Consistently, our results suggested that different
cellular behaviors and biological responses are probably due
to the topographically different microenvironment.
In summary, we demonstrated that FA crystal surfaces,
especially the OR FA surface, mimicked the physical archi-
tecture of enamel, and provided a favorable extracellular
microenvironment for the cells. Moreover, it induced and
stimulated the differentiation of human DPSCs and miner-
alized tissue formation without an MS compared with an
uncoated metal surface. This demonstrates the promising
advantages of FA surfaces as a simple biomimetic model for
dentin regeneration, enamel/dentin/pulp complex creation,
and as a scaffold for hard tissue engineering.
Acknowledgment
This study was supported by NIH grants DE020983.
Disclosure Statement
No competing financial interests exist.
References
1. Yen, A.H., and Sharpe, P.T. Stem cells and tooth tissue en-
gineering. Cell Tissue Res 331, 359, 2008.
2. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi,
S. Postnatal human dental pulp stem cells (DPSCs) in vitro
and in vivo. Proc Natl Acad Sci U S A 97, 13625, 2000.
3. Gronthos, S., Brahim, J., Li, W., Fisher, L.W., Cherman, N., Boyde,
A., DenBesten, P., Robey, P.G., and Shi, S. Stem cell properties
of human dental pulp stem cells. J Dent Res 81, 531, 2002.
4. Chen, H.F., Tang, Z.Y., Liu, J., Sun, K., Chang, S.R., Peters,
M.C., Mansfield, J.F., Czajka-Jakubowska, A., and Clarkson,
B.H. A cellular synthesis of a human enamel-like micro-
structure. Adv Mater 18, 1846, 2006.
5. Liu, J., Jin, T.C., Chang, S., Czajka-Jakubowska, A., and
Clarkson, B.H. Adhesion and growth of dental pulp stem
cells on enamel-like fluorapatite surfaces. J Biomed Mater
Res A 96, 528, 2011.
6. Liu, J., Jin, T., Ritchie, H.H., Smith, A.J., and Clarkson, B.H.
In vitro differentiation and mineralization of human dental
pulp cells induced by dentin extract. In Vitro Cell Dev Biol
41, 232, 2005.
7. Liu, J., Jin, T., Chang, S., Czajka-Jakubowska, A., Zhang, Z.,
Nör, J.E., and Clarkson, B.H. The effect of novel fluorapatite
surfaces on osteoblast-like cell adhesion, growth, and min-
eralization. Tissue Eng Part A 16, 2977, 2010.
GROWTH OF DPSCs ON FLUORAPATITE SURFACES 829
8. Demarco, F.F., Casagrande, L., Zhang, Z., Dong, Z., Tar-
quinio, S.B., Zeitlin, B.D., Shi, S., Smith, A.J., and Nör, J.E.
Effects of morphogen and scaffold porogen on the differ-
entiation of dental pulp stem cells. J Endod 36, 1805, 2010.
9. Li, Y., Lacerda, D.A., Warman, M.L., Beier, D.R., Yoshioka,
H., Ninomiya, Y., Oxford, J.T., Morris, N.P., Andrikopoulos,
K., Ramirez, F., et al. A fibrillar collagen gene, Col11a1, is
essential for skeletal morphogenesis. Cell 80, 423, 1995.
10. Ruchon, A.F., Tenenhouse, H.S., Marcinkiewicz, M., Sieg-
fried, G., Aubin, J.E., Desgroseillers, L., Crine, P., and Boi-
leau, G. Developmental expression and tissue distribution of
Phex protein: effect of the Hyp mutation and relationship to
bone markers. J Bone Miner Res 15, 1440, 2000.
11. Miao, D., Bai, X., Panda, D., McKee, M., Karaplis, A., and
Goltzman, D. Osteomalacia in hyp mice is associated with
abnormal phex expression and with altered bone matrix pro-
tein expression and deposition. Endocrinology 142, 926, 2001.
12. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty,
G. Osf2/Cbfa1: a transcriptional activator of osteoblast dif-
ferentiation. Cell 89, 747, 1997.
13. Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G.,
Geoffroy, V., Amling, M., and Karsenty, G.A. Cbfa1-de-
pendent genetic pathway controls bone formation beyond
embryonic development. Genes Dev 13, 1025, 1999.
14. Quack, I., Vonderstrass, B., Stock, M., Aylsworth, A.S.,
Becker, A., Brueton, L., Lee, P.J., Majewski, F., Mulliken, J.B.,
Suri, M., Zenker, M., Mundlos, S. and Otto, F. Mutation
analysis of core binding factor A1 in patients with cleido-
cranial dysplasia. Am J Hum Genet 65, 1268, 1999.
15. Franceschi, R.T., Xiao, G., Jiang, D., Gopalakrishnan, R.,
Yang, S., and Reith, E. Multiple signaling pathways con-
verge on the Cbfa1/Runx2 transcription factor to regulate
osteoblast differentiation. Connect Tissue Res 44, 109, 2003.
16. Franceschi, R.T., and Xiao, G. Regulation of the osteoblastspecific
transcription factor, Runx2: responsiveness to multiple signal
transduction pathways. J Cell Biochem 88, 446, 2003.
17. D’Souza, R.N., Aberg, T., Gaikwad, J., Cavender, A., Owen,
M., Karsenty, G., and Thesleff, I. Cbfa1 is required for epi-
thelial–mesenchymal interactions regulating tooth develop-
ment in mice. Development 126, 2911, 1999.
18. Aberg, T., Cavender, A., Gaikwad, J.S., Bronckers, A.L.,
Wang, X., Waltimo-Siren, J., Thesleff, I., and D’Souza, R.N.
Phenotypic changes in dentition of Runx2 homozygote-null
mutant mice. J Histochem Cytochem 52, 131, 2004.
19. Bronckers, A.L., Engelse, M.A., Cavender, A., Gaikwad, J.,
and D’Souza, R.N. Cell-specific patterns of Cbfa1 mRNA
and protein expression in postnatal murine dental tissues.
Mech Dev 101, 255, 2001.
20. Liu, H., Li, W., Shi, S., Habelitz, S., Gao, C., and Denbesten,
P. MEPE is downregulated as dental pulp stem cells differ-
entiate. Arch Oral Biol 50, 923, 2005.
21. Chen, S., Rani, S., Wu, Y., Unterbrink, A., Gu, T.T., Gluhak-
Heinrich, J., Chuang, H.H., and MacDougall, M. Differential
regulation of dentin sialophosphoprotein expression by
Runx2 during odontoblast cytodifferentiation. J Biol Chem
280, 29717, 2005.
22. George, A., Sabsay, B., Simonian, P.A., and Veis, A. Char-
acterization of a novel dentin matrix acidic phosphoprotein.
Implications for induction of biomineralization. J Biol Chem
268, 12624, 1993.
23. Qin, C., D’Souza, R., and Feng, J.Q. Dentin matrix protein 1
(DMP1): new and important roles for biomineralization and
phosphate homeostasis. J Dent Res 86, 1134, 2007.
24. Almushayt, A., Narayanan, K., Zaki, A.E., and George, A.
Dentin matrix protein 1 induces cytodifferentiation of dental
pulp stem cells into odontoblasts. Gene Ther 13, 611, 2006.
25. He, G., Dahl, T., Veis, A., and George, A. Nucleation of
apatite crystals in vitro by self-assembled dentin matrix
protein 1. Nat Mater 2, 552, 2003.
26. Gorski, J.P., Huffman, N.T., Chittur, S., Midura, R.J., Black,
C., Oxford, J., and Seidah, N.G. Inhibition of proprotein
convertase SKI-1 blocks transcription of key extracellular
matrix genes regulating osteoblastic mineralization. J Biol
Chem 286, 1836, 2011.
27. Nakashima, M. Induction of dentine in amputated pulp of
dogs by recombinant human bone morphogenetic proteins-2
and - 4 with collagen matrix. Arch Oral Biol 39, 1085, 1994.
28. Rutherford, R.B., Wahle, J., Tucker, M., Rueger, D., and
Charette, M. Induction of reparative dentine formation in
monkeys by recombinant human osteogenic protein-1. Arch
Oral Biol 38, 571, 1993.
29. Marsell, R., and Einhorn, T.A. The role of endogenous bone
morphogenetic proteins in normal skeletal repair. Injury 40,
S4, 2009.
30. Grasser, W.A., Orlic, I., Borovecki, F., Riccardi, K.A., Simic,
P., Vukicevic, S., and Paralkar, V.M. BMP-6 exerts its os-
teoinductive effect through activation of IGF-I and EGF
pathways. Int Orthop 31, 759, 2007.
31. Kelpke, S.S., Zinn, K.R., Rue, L.W., and Thompson, J.A. Site-
specific delivery of acidic fibroblast growth factor stimulates
angiogenic and osteogenic responses in vivo. J Biomed Mater
Res A 71, 316, 2004.
32. Ruch, J.V., Lesot, H., and Begue-Kirn, C. Odontoblast dif-
ferentiation. Int J Dev Biol 39, 51, 1995.
33. Poellmann, M.J., Harrell, P.A., King, W.P., and Wagoner
Johnson, A.J. Geometric microenvironment directs cell
morphology on topographically patterned hydrogel sub-
strates. Acta Biomater 6, 3514, 2010.
34. Discher, D.E., Janmey, P., and Wang, Y.L. Tissue cells feel
and respond to the stiffness of their substrate. Science 310,
1139, 2005.
35. Vogel, V., and Sheetz, M. Local force and geometry sensing
regulate cell functions. Nat Rev Mol Cell Biol 7, 265, 2006.
Address correspondence to:
Jun Liu, Ph.D.
Department of Cariology, Restorative Sciences and Endodontics
2310 I Dental School
University of Michigan
1011 N. University Ave.
Ann Arbor, MI 48109
E-mail: junlc@umich.edu
Longxing Ni, Ph.D.
Department of Operative Dentistry and Endodontics
School of Stomatology
Fourth Military Medical University




Received: November 3, 2011
Accepted: May 1, 2012
Online Publication Date: June 15, 2012
830 WANG ET AL.
This article has been cited by:
1. Gokul Gopinathan, Antonia Kolokythas, Xianghong Luan, Thomas G.H. Diekwisch. 2013. Epigenetic Marks Define the Lineage
and Differentiation Potential of Two Distinct Neural Crest-Derived Intermediate Odontogenic Progenitor Populations. Stem Cells
and Development 22:12, 1763-1778. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links] [Supplemental
Material]
